Mallinckrodt boosts specialty pharma unit with $1.3B Cadence buy
Cadence Pharmaceuticals, the maker of pain and fever drug Ofirmev, will be purchased by Mallinckrodt Pharmaceuticals for around $1.3 billion, or $14 per share. Mallinckrodt said the deal would expand its portfolio of specialty pharmaceutical products and extend its reach into the hospital market, where many Cadence products are used. The deal, expected to be finalized in March, "is consistent with our goal of becoming a leading global specialty pharmaceuticals company," Mallinckrodt CEO and President Mark Trudeau said. Genetic Engineering & Biotechnology News
(2/11), Reuters
(2/11)
Oil and gas industry looks for faster, more efficient way to drill
The oil and natural gas industry is looking for new ways to drill shale reserves with greater speed and efficiency in a bid to produce more oil. Companies such as Halliburton, Schlumberger and Baker Hughes have separately developed new technologies that would help their companies produce more oil from U.S. shale plays. "The industry is in a learning phase. Every well we drill, we learn more. I would maintain that the faster we drill, the faster we are going to learn," said Drillinginfo Vice President of Product Management John Fierstein. FuelFix.com
(2/16)
|
Poplars genetically engineered to produce floral scented chemicals
Biochemists at Washington State University are genetically engineering poplar trees to produce 2-phenylethanol, a chemical that produces a floral scent. The goal, according to researchers, is to produce specialty chemicals to sell in the hope of propping up the biofuel industry. "We've been trying for many decades to understand how plants make these special chemicals that can be used in flavorings, fuels and medicinals, and that seemed like the obvious first place to target," said Norman Lewis, director of the Institute of Biological Chemistry at the university. The Washington Times/The Associated Press
(2/10)
Charge separation could make organic solar cells more efficient
Organic solar cells may be able to increase their typical energy-conversion efficiency of about 10% as a result of university research being done in the area of charge separation. Argonne National Laboratory, imec, and Northwestern, Penn State and Princeton universities have collaborated on the research, which is exploring the use of two different organic semiconductors positioned next to each other. CleanTechnica
(2/7)
|
Energy, Sustainability & Safety |
|
Biological Engineering & Pharmaceuticals |
California Stem Cell receives grant to help develop 3D retina
A $4.5 million grant from the California Institute of Regenerative Medicine has allowed California Stem Cell to tap the University of California at Irvine to continue research and development of transplantable 3D retinas using stem cells, which could lead to treatments for diseases such as age-related macular degeneration and retinitis pigmentosa. CSC will differentiate and culture the stem cells while UC Irvine will conduct in vivo studies at its Sue & Bill Gross Stem Cell Research Center. Healio (free registration)/Primary Care Optometry News
(2/11)
|
Materials & Nanotechnology |
Researchers hone in on 3D printing of cellular materials
Stanford University researchers say they should be able to offer proof of concept by October for 3D printing of cellular materials. The process would produce arrays of cells that excrete non-living structural biomaterials, according to this article. These would mimic things such as wood, minerals and bone and even edibles like meat. TechCrunch
(2/9)
|
Education & Government Update |
|
Ask this question before starting a job hunt
Before starting a job search, ask yourself why you want out of your current job, Scot Herrick writes. "The answer should allow you to filter out your anger at your work, your frustration with all things at the company, and get you to a place of 'By leaving, I will be able to do X with my career,' " he writes. CubeRules.com
(2/12)
|
Access to Biotechnology Progress is free for a limited time
Wiley Online Library, AIChE's publishing partner, is providing free access to the new issue of the bi-monthly journal, Biotechnology Progress, produced for AIChE and its Society for Biological Engineering. Edited by Michael Domach of Carnegie Mellon, the issue's topics range from cell culture and tissue engineering to bioseparations and downstream processing. Read more.
Video tutorial: Material balance basics
ChEnected, AIChE's blog, is featuring a brief "back to basics" video tutorial on material balance. Developed by the faculty at the University of Colorado, Boulder, the video is part of the "Learn ChemE" series. Watch.
|
|
Only in America could a refugee girl from Central Europe become secretary of state."
-- Madeleine Albright, former U.S. secretary of state
|
|
|
More than 45,000 members in 100 countries have joined the American
Institute of Chemical Engineers. It is the focal point for information
exchange at the frontiers of chemical engineering, including energy,
materials, nanotechnology, sustainability, biological engineering, and
chemical plant safety and security. Learn more at
www.aiche.org
or
contact us.
|
Please contact one of our specialists for advertising opportunities,
editorial inquiries, job placements, or any other questions.
Mailing Address: SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
|
|
|